TREATMENT OF ADVANCED CYSTADENOCARCINOMA OF THE OVARY WITH GESTRONOL AND CONTINUOUS ORAL CYCLOPHOSPHAMIDE

被引：14

作者：

GUTHRIE, D

机构：

[1] CRC Oncological Centre, Radiotherapy Department, Newcastle General Hospital, Newcastle Upon Tyne

来源：

BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY | 1979年 / 86卷 / 07期

关键词：

D O I：

10.1111/j.1471-0528.1979.tb10799.x

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

Fifty‐four patients with advanced cystadenocarcinoma of the ovary were treated with gestronol (Depostat), 200 mg/week, by intramuscular injection and continuous oral cyclophosphamide, the dose of the latter being varied to maintain the patient's white cell count at about 1.5 X 109/1. A combined partial and complete remission rate of 76 per cent was obtained. The length of survival depended upon the type of remission and the type of remission was markedly affected by the amount of tumour removed at initial laparotomy. Copyright © 1979, Wiley Blackwell. All rights reserved

引用

页码：497 / 500

页数：4